Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2015-12-22 15:51:12 |
Versijas komentārs | |
Teksts |
Olainfarm Holds Third Quarter 2015 Investor Conference
Webinar
AS „Olainfarm” invites shareholders, investors, mass media
representatives and other stakeholders to join its third quarter
2015 investor conference webinar scheduled on December 22, 2015
at 16:00 (EET). Please note that attendees have to register
for the webinar – detailed information on the registration
process is available below.
Webinar will be hosted by the Member of the Management Board Salvis
Lapiņš. The presentation will be held in
English.
During the webinar Salvis Lapiņš will inform about AS “Olainfarm”
latest activities and analyze the non-audited financial results of
the third quarter 2015.After the presentation investors are welcome
to ask questions.
During the webinar the enclosed presentation will be
presented.
What is webinar?
How to join the webinar?
To join the webinar, we invite you to register via
ej.uz/OLF_3Q2015.
You will be provided with the webinar link and instructions to join
webinar successfully. When joining the webinar for the first time,
you will be asked to download the system application on your
computer which will take only few seconds.
For more information on webinar service please visit:
http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the biggest pharmaceutical
companies in Latvia with more than 40 years of experience in
production of medication and chemical and pharmaceutical products.
A basic principle of company's operations is to produce reliable
and effective top quality products for Latvia and the rest of the
world. Products made by the Group are being exported to more than
35 countries of the world, including the Baltics, Russia, other
CIS, Europe, Asia, North America and
Australia.
Information prepared by: |
Pielikumi |